Gastric Carcinoma: To treat before surgery? Literature revision

Authors

  • Marta Vaz Batista Interna de Oncologia Medica, Hospital Prof. Doutor Fernando Fonseca
  • Ricardo Rocha Interno de Cirurgia Geral, Hospital Prof. Doutor Fernando Fonseca
  • Gonçalo Antalaia Interno de Oncologia Medica, Hospital Prof. Doutor Fernando Fonseca
  • Carla Carneiro Assistente Hospitalar de Cirurgia Geral, Hospital Prof. Doutor Fernando Fonseca
  • Vitor Nunes Diretor de Servico de Cirurgia Geral, Hospital Prof. Doutor Fernando Fonseca
  • Teresa Fiuza Diretora de Servico de Oncologia Medica, Hospital Prof. Doutor Fernando Fonseca

DOI:

https://doi.org/10.57678/rpo.4

Keywords:

gastric carcinoma, neoadjuvant, chemotherapy, radiotherapy

Abstract

Gastric carcinoma is one of the most common cancers worldwide. If the tumor is resectable, surgical approach is the only treatment which might have a curative intent. Even though, the majority of patients suitable for surgery will have recurrent disease, either as local recurrence or as distant metastasis. In order to improve the prognosis of these patients, there has been a crescent interest in the use of antineoplasic treatment before surgery. This article intends to review the evidence towards the use of chemotherapy, radiotherapy and chemoradiotherapy in the neoadjuvant setting.

Downloads

Download data is not yet available.

Downloads

Published

2020-03-31

How to Cite

Vaz Batista, M., Rocha, R., Antalaia, G., Carneiro, C., Nunes, V., & Fiuza, T. (2020). Gastric Carcinoma: To treat before surgery? Literature revision. Portuguese Journal of Oncology, 3(1), 5–12. https://doi.org/10.57678/rpo.4

Issue

Vol. 3 No. 1 (2019): March

Section

Review Articles